Increased platelet adhesion and thrombus formation in a mouse model of Alzheimer's disease

Cellular Signalling

Volumn 28, Issue 12, 2016, Pages 1863-1871

  Canobbio, Ilaria ^a   Visconte, Caterina ^a   Oliviero, Barbara ^b   Guidetti, Gianni ^a   Zarà, Marta ^a   Pula, Giordano ^c   Torti, Mauro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Adhesion; Alzheimer's disease; Amyloid; Platelets; Thrombus formation

Indexed keywords

AMYLOID PROTEIN; COLLAGEN; FIBRINOGEN; FOCAL ADHESION KINASE 2; GLYCOPROTEIN; INTEGRIN; INTEGRIN ALPHA2BETA3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN LIGHT CHAIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; FIBRINOGEN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; GENE MUTATION; GENE OVEREXPRESSION; MOUSE; MOUSE MODEL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE; THROMBUS; UPREGULATION; WILD TYPE; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; HUMANS; MICE, TRANSGENIC; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 84986628106     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.08.017     Document Type: Article

References (39)

1. [1] World Alzheimer Report. http://www.worldalzreport2015.org/downloads/world-alzheimer-report2015.pdf, 2015.
2. [2] Yamada, M., Cerebral amyloid angiopathy: emerging concepts. J. Stroke 17:1 (Jan 2015), 17–30, 10.5853/jos.2015.17.1.17.
3. [3] Gandy, S., The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. 115:5 (May 2005), 1121–1129.
4. [4] Iqbal, K., Liu, F., Gong, C.X., Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12:1 (Jan 2016), 15–27, 10.1038/nrneurol.2015.225.
5. [5] Honig, L.S., Tang, M.X., Albert, S., Costa, R., Luchsinger, J., Manly, J., Stern, Y., Mayeux, R., Stroke and the risk of Alzheimer disease. Arch. Neurol. 60:12 (Dec 2003), 1707–1712.
6. [6] Mielke, M.M., Rosenberg, P.B., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., Norton, M., Rabins, P.V., Green, R.C., Welsh-Bohmer, K.A., Breitner, J.C., Munger, R., Lyketsos, C.G., Vascular factors predict rate of progression in Alzheimer disease. Neurology 69:19 (Nov 6, 2007), 1850–1858.
7. [7] Viswanathan, A., Greenberg, S.M., Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 70:6 (Dec 2011), 871–880, 10.1002/ana.22516.
8. [8] Casoli, T., Di Stefano, G., Balietti, M., Solazzi, M., Giorgetti, B., Fattoretti, P., Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets. Biogerontology 11:5 (Oct 2010), 627–633, 10.1007/s10522-010-9281-8.
9. [9] Evin, G., Li, Q.X., Platelets and Alzheimer's disease: potential of APP as a biomarker. World J. Psychiatry 2:6 (Dec 22, 2012), 102–113, 10.5498/wjp.v2.i6.102.
10. [10] Canobbio, I., Abubaker, A.A., Visconte, C., Torti, M., Pula, G., Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front. Cell. Neurosci., 9, Mar 3, 2015, 65, 10.3389/fncel.2015.00065.
11. [11] Van Nostrand, W.E., Wagner, S.L., Suzuki, M., Choi, B.H., Farrow, J.S., Geddes, J.W., Cotman, C.W., Cunningham, D.D., Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature 341:6242 (Oct 12, 1989), 546–549.
12. [12] Li, Q.X., Whyte, S., Tanner, J.E., Evin, G., Beyreuther, K., Masters, C.L., Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab. Investig. 78:4 (Apr 1998), 461–469.
13. [13] Eisele, Y.S., Obermüller, U., Heilbronner, G., Baumann, F., Kaeser, S.A., Wolburg, H., Walker, L.C., Staufenbiel, M., Heikenwalder, M., Jucker, M., Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:6006 (Nov 12, 2010), 980–982, 10.1126/science.1194516.
14. [14] Sutcliffe, J.G., Hedlund, P.B., Thomas, E.A., Bloom, F.E., Hilbush, B.S., Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease. J. Neurosci. Res. 89:6 (Jun 2011), 808–814, 10.1002/jnr.22603.
15. [15] Shen, M.Y., Hsiao, G., Fong, T.H., Chou, D.S., Sheu, J.R., Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase Cgamma2-protein kinase C pathway in platelet activation. Pharmacol. Res. 57:2 (Feb 2008), 151–158, 10.1016/j.phrs.2008.01.004.
16. 2 + and ADP in aggregation and thrombus formation. Biochem. J. 462:3 (Sep 15, 2014), 513–523, 10.1042/BJ20140307.
17. [17] Sonkar, V.K., Kulkarni, P.P., Dash, D., Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization. FASEB J. 28:4 (2014 Apr), 1819–1829, 10.1096/fj.13-243691.
18. [18] Gowert, N.S., Donner, L., Chatterjee, M., Eisele, Y.S., Towhid, S.T., Münzer, P., Walker, B., Ogorek, I., Borst, O., Grandoch, M., Schaller, M., Fischer, J.W., Gawaz, M., Weggen, S., Lang, F., Jucker, M., Elvers, M., Blood platelets in the progression of Alzheimer's disease. PLoS One, 9(2), Feb 28, 2014, e90523, 10.1371/journal.pone.0090523.
19. [19] Grammas, P., Martinez, J., Sanchez, A., Yin, X., Riley, J., Gay, D., Desobry, K., Tripathy, D., Luo, J., Evola, M., Young, A., A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. J. Alzheimers Dis. 40:3 (2014), 619–630, 10.3233/JAD-2014-132057.
20. [20] Neumann, K., Farías, G., Slachevsky, A., Perez, P., Maccioni, R.B., Human platelets tau: a potential peripheral marker for Alzheimer's disease. J. Alzheimers Dis. 25:1 (2011), 103–109, 10.3233/JAD-2011-101641.
21. [21] Mukaetova-Ladinska, E.B., Abdell-All, Z., Andrade, J., da Silva, J.A., Boksha, I., Burbaeva, G., Kalaria, R.J., O'Brien, J.T., Platelet tau protein as a potential peripheral biomarker in Alzheimer's disease: an explorative study. Curr. Alzheimer Res., 2013.
22. [22] Veitinger, M., Varga, B., Guterres, S.B., Zellner, M., Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?. Acta Neuropathol. Commun., 2, Jun 16, 2014, 65, 10.1186/2051-5960-2-65.
23. [23] Di Luca, M., Colciaghi, F., Pastorino, L., Borroni, B., Padovani, A., Cattabeni, F., Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein. Eur. J. Pharmacol. 405:1–3 (Sep 29, 2000), 277–283.
24. [24] Borroni, B., Agosti, C., Marcello, E., Di Luca, M., Padovani, A., Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp. Gerontol. 45:1 (Jan 2010), 53–56, 10.1016/j.exger.2009.08.004.
25. [25] Sevush, S., Jy, W., Horstman, L.L., Mao, W.W., Kolodny, L., Ahn, Y.S., Platelet activation in Alzheimer disease. Arch. Neurol. 55:4 (Apr 1998), 530–536.
26. [26] Stellos, K., Panagiota, V., Kögel, A., Leyhe, T., Gawaz, M., Laske, C., Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. J. Cereb. Blood Flow Metab. 30:11 (Nov 2010), 1817–1820, 10.1038/jcbfm.2010.140.
27. [27] Laske, C., Clinical and biomarker changes in Alzheimer's disease. N. Engl. J. Med., 367(21), Nov 22, 2012, 2050, 10.1056/NEJMc1211767#SA1 (author reply 2051-2).
28. [28] Prodan, C.I., Ross, E.D., Vincent, A.S., Dale, G.L., Rate of progression in Alzheimer's disease correlates with coated-platelet levels—a longitudinal study. Transl. Res. 152:3 (2008 Sep), 99–102, 10.1016/j.trsl.2008.07.001.
29. [29] Jarre, A., Gowert, N.S., Donner, L., Münzer, P., Klier, M., Borst, O., Schaller, M., Lang, F., Korth, C., Elvers, M., Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease. Cell. Signal. 26:9 (Sep 2014), 2040–2050, 10.1016/j.cellsig.2014.05.019.
30. [30] Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., LaFerla, F.M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:3 (Jul 31, 2003), 409–421.
31. [31] Plagg, B., Marksteiner, J., Kniewallner, K.M., Humpel, C., Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Biogerontology 16:4 (Aug 2015), 543–558, 10.1007/s10522-015-9580-1.
32. [32] Canobbio, I., Cipolla, L., Consonni, A., Momi, S., Guidetti, G., Oliviero, B., Falasca, M., Okigaki, M., Balduini, C., Gresele, P., Torti, M., Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2 +)-dependent tyrosine kinase Pyk2. Blood 121:4 (Jan 24, 2013), 648–657, 10.1182/blood-2012-06-438762.
33. [33] Cipolla, L., Consonni, A., Guidetti, G., Canobbio, I., Okigaki, M., Falasca, M., Ciraolo, E., Hirsch, E., Balduini, C., Torti, M., The proline-rich tyrosine kinase Pyk2 regulates platelet integrin αIIbβ3 outside-in signaling. J. Thromb. Haemost. 11:2 (Feb 2013), 345–356.
34. [34] Consonni, A., Cipolla, L., Guidetti, G.F., et al. Role and regulation of phosphatidylinositol 3-kinase beta in platelet integrin alpha2bet1 signaling. Blood 119:3 (2012), 847–856.
35. [35] Cho, S.M., Lee, S., Yang, S.H., Kim, H.Y., Lee, M.J., Kim, H.V., Kim, J., Baek, S., Yun, J., Kim, D., Kim, Y.K., Cho, Y., Woo, J., Kim, T.S., Kim, Y., Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice. Sci. Rep., 6, 2016, 20185.
36. [36] Li, Q.X., Berndt, M.C., Bush, A.I., Rumble, B., Mackenzie, I., Friedhuber, A., Beyreuther, K., Masters, C.L., Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood 84:1 (Jul 1, 1994), 133–142.
37. [37] Canobbio, I., Catricalà, S., Di Pasqua, L.G., Guidetti, G., Consonni, A., Manganaro, D., Torti, M., Immobilized amyloid Aβ peptides support platelet adhesion and activation. FEBS Lett. 587:16 (Aug 19, 2013), 2606–2611.
38. [38] Bilkei-Gorzo, A., Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacol. Ther. 142:2 (May 2014), 244–257.
39. [39] Jackson, S.P., Nesbitt, W.S., Westein, E., Dynamics of platelet thrombus formation. J. Thromb. Haemost. 7:Suppl. 1 (Jul 2009), 17–20.